372 related articles for article (PubMed ID: 28322709)
21. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
Hien TT; Thuy-Nhien NT; Phu NH; Boni MF; Thanh NV; Nha-Ca NT; Thai le H; Thai CQ; Toi PV; Thuan PD; Long le T; Dong le T; Merson L; Dolecek C; Stepniewska K; Ringwald P; White NJ; Farrar J; Wolbers M
Malar J; 2012 Oct; 11():355. PubMed ID: 23101492
[TBL] [Abstract][Full Text] [Related]
22. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
[TBL] [Abstract][Full Text] [Related]
23. Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
Yeka A; Wallender E; Mulebeke R; Kibuuka A; Kigozi R; Bosco A; Kyambadde P; Opigo J; Kalyesubula S; Senzoga J; Vinden J; Conrad M; Rosenthal PJ
J Infect Dis; 2019 Mar; 219(7):1112-1120. PubMed ID: 30418593
[TBL] [Abstract][Full Text] [Related]
24. Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.
Leang R; Taylor WR; Bouth DM; Song L; Tarning J; Char MC; Kim S; Witkowski B; Duru V; Domergue A; Khim N; Ringwald P; Menard D
Antimicrob Agents Chemother; 2015 Aug; 59(8):4719-26. PubMed ID: 26014949
[TBL] [Abstract][Full Text] [Related]
25. Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.
Keating GM
Drugs; 2012 May; 72(7):937-61. PubMed ID: 22515619
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam.
Nguyen DV; Nguyen QP; Nguyen ND; Le TT; Nguyen TD; Dinh DN; Nguyen TX; Bui D; Chavchich M; Edstein MD
Antimicrob Agents Chemother; 2009 Aug; 53(8):3534-7. PubMed ID: 19528277
[TBL] [Abstract][Full Text] [Related]
27. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Ashley EA; Krudsood S; Phaiphun L; Srivilairit S; McGready R; Leowattana W; Hutagalung R; Wilairatana P; Brockman A; Looareesuwan S; Nosten F; White NJ
J Infect Dis; 2004 Nov; 190(10):1773-82. PubMed ID: 15499533
[TBL] [Abstract][Full Text] [Related]
28. Pyronaridine-Artesunate (Pyramax) for Treatment of Artemisinin- and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of Vietnam.
Manh ND; Thanh NV; Quang HH; Van NTT; San NN; Phong NC; Birrell GW; Edstein MD; Edgel KA; Martin NJ; Chavchich M
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0027621. PubMed ID: 34570647
[TBL] [Abstract][Full Text] [Related]
29. Open label randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam.
Thanh NX; Trung TN; Phong NC; Thien NX; Dai B; Shanks GD; Chavchich M; Edstein MD
Trop Med Int Health; 2009 May; 14(5):504-11. PubMed ID: 19320869
[TBL] [Abstract][Full Text] [Related]
30. Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand.
Boonyalai N; Thamnurak C; Sai-Ngam P; Ta-Aksorn W; Arsanok M; Uthaimongkol N; Sundrakes S; Chattrakarn S; Chaisatit C; Praditpol C; Fagnark W; Kirativanich K; Chaorattanakawee S; Vanachayangkul P; Lertsethtakarn P; Gosi P; Utainnam D; Rodkvamtook W; Kuntawunginn W; Vesely BA; Spring MD; Fukuda MM; Lanteri C; Walsh D; Saunders DL; Smith PL; Wojnarski M; Sirisopana N; Waters NC; Jongsakul K; Gaywee J
Sci Rep; 2021 Jun; 11(1):13419. PubMed ID: 34183715
[TBL] [Abstract][Full Text] [Related]
31. Baseline
Robert MG; Foguim Tsombeng F; Gendrot M; Diawara S; Madamet M; Kounta MB; Wade KA; Fall M; Gueye MW; Benoit N; Nakoulima A; Bercion R; Amalvict R; Fall B; Wade B; Diatta B; Pradines B
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782997
[TBL] [Abstract][Full Text] [Related]
32. Changing Antimalarial Drug Sensitivities in Uganda.
Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
[TBL] [Abstract][Full Text] [Related]
33. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B
Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646
[TBL] [Abstract][Full Text] [Related]
34. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.
Witkowski B; Duru V; Khim N; Ross LS; Saintpierre B; Beghain J; Chy S; Kim S; Ke S; Kloeung N; Eam R; Khean C; Ken M; Loch K; Bouillon A; Domergue A; Ma L; Bouchier C; Leang R; Huy R; Nuel G; Barale JC; Legrand E; Ringwald P; Fidock DA; Mercereau-Puijalon O; Ariey F; Ménard D
Lancet Infect Dis; 2017 Feb; 17(2):174-183. PubMed ID: 27818097
[TBL] [Abstract][Full Text] [Related]
35. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
36. A Variant PfCRT Isoform Can Contribute to
Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
mBio; 2017 May; 8(3):. PubMed ID: 28487425
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium falciparum Plasmepsin 2 Duplications, West Africa.
Inoue J; Silva M; Fofana B; Sanogo K; Mårtensson A; Sagara I; Björkman A; Veiga MI; Ferreira PE; Djimde A; Gil JP
Emerg Infect Dis; 2018 Aug; 24(8):1591-3. PubMed ID: 29798744
[TBL] [Abstract][Full Text] [Related]
38. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
[TBL] [Abstract][Full Text] [Related]
39. Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
McLean ARD; Indrasuta C; Khant ZS; Phyo AK; Maung SM; Heaton J; Aung H; Aung Y; Soe K; Swe MMM; von Seidlein L; Tun NN; Tun KM; Day NPJ; Ashley EA; Hlaing T; Kyaw TT; Dondorp AM; Imwong M; White NJ; Smithuis FM
Lancet Infect Dis; 2021 Nov; 21(11):1579-1589. PubMed ID: 34147154
[TBL] [Abstract][Full Text] [Related]
40. Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.
Parobek CM; Parr JB; Brazeau NF; Lon C; Chaorattanakawee S; Gosi P; Barnett EJ; Norris LD; Meshnick SR; Spring MD; Lanteri CA; Bailey JA; Saunders DL; Lin JT; Juliano JJ
Genome Biol Evol; 2017 Jun; 9(6):1673-1686. PubMed ID: 28854635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
